Jiskoot, Wim

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates

Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research

Field-Flow Fractionation TechniquesNanoparticle-Based Drug Delivery

Cited by 1,885

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 1,566

Addressing the Cold Reality of mRNA Vaccine Stability

Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W., & Mastrobattista, E. (2021) · Journal of Pharmaceutical Sciences

SARS-CoV-2 and COVID-19 ResearchRNA Interference and Gene Delivery

Cited by 517

Strategies for the assessment of protein aggregates in pharmaceutical biotech product development

den Engelsman, J., Garidel, P., Smulders, R., Koll, H., Smith, B., Bassarab, S., Seidl, A., Hainzl, O., & Jiskoot, W. (2011) · Pharmaceutical Research

Protein purification and stabilityBiosimilars and Bioanalytical Methods

Cited by 348

Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products

Carpenter, J. F., Randolph, T. W., Jiskoot, W., Crommelin, D. J. A., Middaugh, C. R., & Winter, G. (2010) · Journal of Pharmaceutical Sciences

Protein purification and stabilityBiosimilars and Bioanalytical Methods

Cited by 202

Immunogenicity of therapeutic proteins: the use of animal models

Brinks, V., Jiskoot, W., & Schellekens, H. (2011) · Pharmaceutical Research

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research

Cited by 164

Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins

Tu, J., Boyle, A. L., Friedrich, H., Bomans, P. H. H., Bussmann, J., Sommerdijk, N. A. J. M., Jiskoot, W., & Kros, A. (2016) · ACS Applied Materials & Interfaces

Mesoporous Materials and CatalysisNanoparticle-Based Drug Delivery

Cited by 143

Stabilization of proteins in dry powder formulations using supercritical fluid technology

Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W. (2004) · Pharmaceutical Research

Phase Equilibria and ThermodynamicsProtein purification and stability

Cited by 111

In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice

Filipe, V., Que, I., Carpenter, J. F., Löwik, C., & Jiskoot, W. (2014) · Pharmaceutical Research

Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability

Cited by 39

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines

van den Ende, T. C., Heuts, J. M. M., Gential, G. P. P., Visser, M., van de Graaff, M. J., Ho, N. I., Jiskoot, W., Valentijn, A. R. P. M., Meeuwenoord, N. J., Overkleeft, H. S., et al. (2021) · ChemBioChem

Immunotherapy and Immune ResponsesChemical Synthesis and Analysis

Cited by 9